We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Assay for Thyroid-Stimulating Hormone

By HospiMedica staff writers
Posted on 16 Jun 2006
A new immunoassay for thyroid-stimulating hormone (TSH) is designed for the diagnosis of hyperthyroidism and hypothyroidism.

The ability to achieve third-generation sensitivity is essential for most TSH assays, since it yields information that is useful to clinicians referring patients with subnormal TSH concentrations, according to Olympus Life and Material Science Europa (Hamburg, Germany), which developed the assay. More...


The clinical benchmark for TSH is not its analytic sensitivity but its functional sensitivity. Functional sensitivity for TSH is normally defined as the lowest concentration at which the interassay coefficient of variation is ? 20%. This demonstrates the ability of the assay to discriminate euthyroid levels (0.4-4.0 µlU/ml) from the very low levels (< 0.01 µlU/ml) obtained in patients with thyrotoxicosis.

Olympus has announced that the latest performance verification of the assay on the new Olympus AU3000i immunoassay system delivered excellent functional sensitivity (fourth generation: ? 20% coefficient of variation (CV) @ 0.002 µlU/ml) and analytic sensitivity (< 0.001 µlU/ml). Based on this performance, the company concludes that the AU3000i TSH assay is a very sensitive and precise method for the detection of human TSH in both serum and plasma. These results would seem to justify the new assay as being regarded as fourth generation.



Related Links:
Olympus Life and Material Science

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.